AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Big Stocks Moving Higher on Tuesday: Mesoblast, Atai Life Sciences, Melco Resorts & Entertainment
ByAinvest
Wednesday, Jul 2, 2025 12:02 pm ET1min read
US stocks were mixed, with the Dow Jones index gaining over 250 points on Tuesday. Mesoblast Limited MESO shares rose 11.8% to $12.18 after announcing alignment with the FDA on items required for filing a Biologics License Application for Revascor for ischemic heart failure. Other stocks recording gains include Atai Life Sciences N.V. ATAI, McEwen Inc. MUX, Bloomin’ Brands, Inc. BLMN, Citius Oncology, Inc. CTOR, Melco Resorts & Entertainment Limited MLCO, Studio City International Holdings Limited MSC, IREN Limited IREN, Wynn Resorts, Limited WYNN, Las Vegas Sands Corp. LVS, and Advance Auto Parts, Inc. AAP.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet